One Case of Agranulocytosis Complicated with Maxillofacial Infection Induced by Methimazole Tablets

Abstract

CLC Number:

R994.11

YAN Hui-yu, MIAO Qiu-li, ZHANG Si-xi. One Case of Agranulocytosis Complicated with Maxillofacial Infection Induced by Methimazole Tablets[J]. Chinese Journal of Pharmacovigilance, 2018, 15(6): 370-371.

References

[1] 杨华,魏晶,王嘉仡,等. 药品不良反应/事件报告评价方法研究[J].中国药物警戒,2009,6(10):581-584.
[2] Kaufman D W, Kelly J P, Jurgelon J M.Drugs in the aetiology of agranulocytosis and aplastic anaemia[J]. Eur J Haematol Suppl,1996,60:23-30.
[3] Ross D S, Burch H B, Cooper D S, et al.2016 American thyroid association guidelines for diagnosis and management of hyperthy-roidism and other causes of thyrotoxicosis[J].Thyroid, 2016,26(10):1343-1421.
[4] Minamitani K, Oikawa J, Wataki K,et al.A Report of three girls with antithyroid drug-induced agranulocytosis; retrospective analysis of 18 cases aged 15 years or younger reported between 1995 and 2009[J]. Clin Pediatr Endocrinol, 2011,20(2):39-46.
[5] Andersohn F, Konzen C, Garbe E.Systematic review: agranulo-cytosis induced by nonchemotherapy drugs[J]. Ann Intern Med,2007,146(9):657-665.
[6] Zhang J, Xiao Y, Niu Q X, et al.Clinical analysis for severe agranulocytosis caused by methimazole[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015,20(3):293-295.
[7] Yang J, Zhu Y J, Zhong J J,et al.Characteristics of Antithyroid Drug-Induced Agranulocytosis in Patients with Hyperthyroidism: A Retrospective Analysis of 114 Cases in a Single Institution in China Involving 9690 Patients Referred for Radioiodine Treatment Over 15 Years[J]. Thyroid,2016 :26(5):627-633.
[8] Yasuda K, Miyoshi Y, Tachibana M, et al.Relationship between dose of antithyroid drugs and adverse events in pediatric patients with Graves' disease[J]. Clin Pediatr Endocrinol, 2017 26(1):1-7.
[9] Puthenpura V, Desai K, Baue A, et al.Delayed methimazole-induced agranulocytosis in a 6-year old patient with Graves' disease[J]. Int J Pediatr Endocrinol,2016, (1):16.
[10] Cheung C L, Sing C W, Tang C S, et al.HLA-B*38:02:01 predicts carbimazole/ methimazole-induced agranulocytosis[J]. Clin Pharmacol Ther,2016 ,99(5):555-61.
[11] David S, Cooper M D.Antithyroid drugs[J]. N Engl J Med,2005,352(9) :905-917.

[1]	SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131.
[2]	ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136.
[3]	BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140.
[4]	JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166.
[5]	LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180.
[6]	FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184.
[7]	ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189.
[8]	WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194.
[9]	LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198.
[10]	XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203.
[11]	GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207.
[12]	FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210.
[13]	LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212.
[14]	CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218.
[15]	ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222.